Form 8-K - Current report:
SEC Accession No. 0001213900-15-005621
Filing Date
2015-08-03
Accepted
2015-08-03 08:06:16
Documents
3
Period of Report
2015-07-29
Items
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT f8k072915_actiniumpharmac.htm 8-K 16643
2 LETTER TO SHAREHOLDERS f8k072915ex99i_actinium.htm EX-99.1 28109
3 GRAPHIC img001.jpg GRAPHIC 8744
  Complete submission text file 0001213900-15-005621.txt   58180
Mailing Address 546 5TH AVENUE, 14TH FLOOR NEW YORK NY 10036
Business Address 546 5TH AVENUE, 14TH FLOOR NEW YORK NY 10036 212-300-2131
Actinium Pharmaceuticals, Inc. (Filer) CIK: 0001388320 (see all company filings)

EIN.: 880378336 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36374 | Film No.: 151021075
SIC: 2834 Pharmaceutical Preparations